Equities

Waystar Holding Corp

WAY:NSQ

Waystar Holding Corp

Actions
Health CareHealth Care Providers
  • Price (USD)31.68
  • Today's Change0.540 / 1.73%
  • Shares traded1.43m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 17:26 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 17-Oct-24
  • 14-Nov-24
  • 22-Nov-24
Select bar for recommendation details.
Recommendations22-Nov-24
Buy3
Outperform7
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 9 analysts offering 12 month price targets for Waystar Holding Corp have a median target of 36.00, with a high estimate of 40.00 and a low estimate of 30.00. The median estimate represents a 15.61% increase from the last price of 31.14.
High28.5%40.00
Med15.6%36.00
Low-3.7%30.00

Earnings history & estimates in USD

On Nov 06, 2024, Waystar Holding Corp reported 3rd quarter 2024 earnings of 0.14 per share.
Average growth rate+250.00%
More ▼

Revenue history & estimates in USD

Waystar Holding Corp had 3rd quarter 2024 revenues of 240.11m. This bettered the 223.80m consensus of the 8 analysts covering the company. The same period last year the company did not report revenues.
Average growth rate+2.37%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.